← All stocks

Greenwich LifeSciences, Inc.

GLSI No buying or selling
CIK 0001799788 #3849 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

2 insiders · 0 transactions
120×

Snehal Patel holds 120 times base salary in stock. $73.51M of shares against $612.56K in salary for 2024.

Salary from the company's own proxy. The shares are what Snehal Patel last reported holding, valued at $13.10, the price Common Stock was last bought or sold at on the open market here, on 29 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Patel Snehal
CEO and CFO
5,611,402
$73.51M
+1.4%
Thompson Jaye
VP Clinical Reg Affairs
264,148
$3.46M
+0.4%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 29 Sep 2020